# Scott Burkhart
Chief Operating Officer
## Career chronology
- **More than a decade before October 2021: Westpac and Commonwealth Bank of Australia** — Corporate and institutional banking. [Our People]() (Our People, Scott Burkhart biography, lines 10–15)
- **Joined October 2021; COO until CEO appointment: Zeotech Limited** — Chief Operating Officer. [Executive Management Changes]() (p. 1, appointment release)
- **1 November 2023 to 9 September 2024: Zeotech Limited** — Chief Executive Officer. [Executive Management Changes]() (pp. 1–2, CEO change and employment terms)
- **From 9 September 2024: Zeotech Limited** — Chief Operating Officer. [Annual Report 2025]() (p. 25, service agreement amended to COO)
## Education and qualifications
### Education and professional qualification [zeo_scott_burkhart_education]
As reported by cited source; accessed 2026-10-09 · issuer reported · low materiality
The issuer reports a Bachelor of Business (Management and Economics) from Auckland University of Technology. Credential not independently verified.
**Attribution:** Responsibility not applicable. Credential statements are issuer-reported; no university or professional-body verification was obtained.
**Relevance:** Relevant to role-fit assessment and subject to verification gap.
[Executive Management Changes]() (p. 1, executive management changes)
## Contributions and company outcomes
### FY2026 project and commercial milestones [zeo_scott_burkhart_fy26_delivery]
FY2026 through 2026-06-30; subsequent status through 2026-09-21 · issuer reported · medium materiality
During the cited period Zeotech reported the binding MSI DSO offtake, 2,300-tonne test-pit campaign, AusPozz concrete demonstration and methane-control field results, while Toondoon remained pre-commercial with approvals/logistics still progressing. These are company-level outcomes; the evidence does not isolate COO's personal contribution or establish booked DSO/AusPozz sales.
**Attribution:** Role overlaps event; causation unproven. Management responsibility overlapped the company period, but personal causal contribution is not documented.
**Relevance:** Relevant to delivery assessment; distinguish test/contract milestones from commercial production and realized cash revenue.
[Annual Report to shareholders]() (FY2026 annual report, operating review and KMP disclosures); [Quarterly Activities and Appendix 5B Cash Flow Report]() (pp. 1–8, activities report)
## Business failures and setbacks
### Pre-commercial status and funding dependence [zeo_scott_burkhart_fy26_funding]
FY2026 to 2026-06-30 · issuer reported · medium materiality
FY2026 reporting showed the Group remained pre-commercial, with a larger annual loss and operating cash outflow than the prior year; the annual report disclosed that additional funding may be needed to continue operations and develop assets. This is a company-level execution/funding risk during the executive's tenure, not evidence of personal misconduct or sole responsibility.
**Attribution:** Role overlaps event; causation unproven. The COO role overlapped the reported period; no personal causal attribution is established.
**Relevance:** Material to assessing delivery and capital allocation for a development-stage company.
[Annual Report to shareholders]() (FY2026 annual report, financial statements and going-concern funding risk)
## Litigation and enforcement
### Abercorn project milestone-rights litigation settled [zeo_scott_burkhart_abercorn_settlement]
2023; acquisition term sheet dated 2019-08-09 · issuer reported · medium materiality
Zeotech reported that court-ordered mediation over milestone performance rights issued as consideration for the 2019 Abercorn acquisition concluded in 2023, with a binding settlement/release and discontinuance of both proceedings conditional on shareholder approval. The disclosure does not describe any finding of wrongdoing by the named executive; the dispute originated in a pre-appointment transaction and settlement terms were company-level.
**Attribution:** Role overlaps event; causation unproven. The MD/CEO roles overlapped settlement execution/oversight; no personal involvement or wrongdoing is documented.
**Relevance:** Relevant as company legal/governance context; resolution status disclosed as settlement, not adjudication of merits.
[Quarterly Activities Report (March 2023 quarter)]() (p. 8, Settlement of legal proceedings)
## Suitability for the current role
### Role relevance and evidenced background [zeo_scott_burkhart_fit]
Background reviewed through 2026-10-09 · analyst inference · low materiality
The issuer biography supports relevant background for the assigned role. Current title in the selected roster: Chief Operating Officer. This supports role relevance at a high level; the public evidence reviewed does not establish personal causal responsibility for employer or project outcomes.
**Attribution:** Responsibility not applicable. Role-fit judgment based on the selected roster and issuer-reported professional background; no causal claim is made.
**Relevance:** Relevant to the current Chief Operating Officer responsibilities, subject to the evidence limitations recorded below.
[Our People]() (Executive biography or corporate-directory entry for the named person)
## Evidence gaps
- Prior-career date granularity and qualifications are mainly issuer-reported and not independently verified.
- Company milestones are not personally attributable from available evidence; the company remained pre-commercial at the cutoff.
- No exhaustive criminal, sanctions, court, regulator, safety, environment or qualification check was performed.